Author: Maslow, Joel
Title: GeneOne Life Science Document date: 2018_10_26
ID: w7hf3kji_11
Snippet: The MERS-CoV DNA vaccine moved into Phase II trials in the summer of 2018. GLS-1027 and quinine are expected to enter into Phase II trials within the next year. mRNA vaccine products are in the design phase......
Document: The MERS-CoV DNA vaccine moved into Phase II trials in the summer of 2018. GLS-1027 and quinine are expected to enter into Phase II trials within the next year. mRNA vaccine products are in the design phase.
Search related documents:
Co phrase search for related documents- design phase and vaccine product: 1
- dna vaccine and Phase II trial: 1
- dna vaccine and vaccine product: 1, 2
- mRNA vaccine product and vaccine product: 1
Co phrase search for related documents, hyperlinks ordered by date